Css LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Css LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $176,280 - $217,800	4,000 Added 23.53%	21,000 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $367,220 - $515,914	-8,600 Reduced 33.59%	17,000 $791,000
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $215,000 - $328,200	5,000 Added 24.27%	25,600 $1.46 Million
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $1.12 Million - $1.8 Million	-29,000 Reduced 58.47%	20,600 $1.26 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $876,480 - $1.33 Million	-24,900 Reduced 33.42%	49,600 $2.6 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $1.35 Million - $2 Million	-47,000 Reduced 38.68%	74,500 $2.78 Million
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $2.33 Million - $3.53 Million	79,400 Added 188.6%	121,500 $4.96 Million
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $896,280 - $1.15 Million	29,100 Added 223.85%	42,100 $1.43 Million
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $296,418 - $409,194	12,700 Added 4233.33%	13,000 $414,000
Q3 2020 Nov 16, 2020	SELL	$17.61 - $31.86 $523,017 - $946,242	-29,700 Reduced 99.0%	300 $8,000
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $515,165 - $956,376	-35,900 Reduced 54.48%	30,000 $770,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $478,434 - $2.54 Million	65,900 New	65,900 $2.26 Million

381

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $11.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.